u4/u6 snRNP Inhibitors

U4/U6 snRNP inhibitors are a class of compounds that interfere with the function of the U4/U6 small nuclear ribonucleoproteins (snRNPs), which are critical components of the spliceosome. The spliceosome is a complex molecular machine responsible for the removal of introns from pre-mRNA in a process known as RNA splicing. U4 and U6 snRNPs, together with U5 snRNP, form a core tri-snRNP complex that is essential for the splicing reaction. Specifically, the U4 snRNA forms base-pair interactions with U6 snRNA to sequester U6 in an inactive state. During the splicing process, U4 is displaced, allowing U6 to form new interactions with other spliceosomal components, facilitating catalytic activation of the spliceosome. Inhibitors that target U4/U6 snRNPs disrupt these essential interactions, leading to impaired splicing.

U4/U6 snRNP inhibitors are designed to interfere with the structural or functional integrity of the U4 and U6 snRNAs or their associated proteins within the snRNP complex. These inhibitors may affect the stability of the U4/U6 base pairing or alter the conformational changes required for spliceosome assembly and function. The molecular mechanism of these inhibitors often involves binding to critical regions within the U4/U6 complex or interfering with the recruitment of other essential splicing factors. By modulating the activity of the U4/U6 snRNP, these compounds provide valuable tools for studying the mechanistic aspects of RNA splicing and the dynamic processes involved in spliceosome activation. This interference with splicing can also shed light on the regulatory roles of the spliceosome in gene expression.